Symbols

NOVT

Novanta·NASDAQ

--(--)

NOVT fundamentals

NOVT Q4 2025 Earnings

Novanta (NOVT) released its earnings on Feb 23, 2026: revenue was 255.73M (YoY +7.41%), beat estimates; EPS was 0.88 (YoY +15.79%), met estimates.

Revenue / YoY

255.73M

+7.41%

EPS / YoY

0.88

+15.79%

Report date

Feb 23, 2026

NOVT Earnings Call Summary for Q4,2025

Revenue & Bookings Surge: Q4 2025 revenue $981M (+9% reported), bookings +25% YoY (book-to-bill 1.11), with all businesses hitting double-digit bookings growth.
New Product Dominance: New product revenue up 60% YoY (80% Q4), Vitality Index 24%, driven by advanced surgery and medical consumables.
2026 Growth Outlook: 4%-6% revenue growth, 47% gross margin, $145M-$185M operating cash flow, and EPS $3.50-$3.65 (+8%-11%).
Strategic Momentum: $1.5B M&A pipeline, GPU drilling AI infrastructure growth, and regional manufacturing completion to reduce costs.
Balance Sheet Strength: $381M cash, negative net debt, and $1.5B acquisition capacity post-equity raise.

Earnings

EPS

Revenue

Revenue & Expenses

NOVT has released its 2025 Q4 earnings report, with revenue of 258.35M, reflecting a YoY change of 8.52%, and net profit of 17.47M, showing a YoY change of 6.12%. The Sankey diagram below clearly presents NOVT's revenue sources and cost distribution.

Key Indicators

Novanta (NOVT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Novanta (NOVT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Novanta (NOVT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Novanta (NOVT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown